Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Reduced brain amyloid burden in elderly patients with narcolepsy type 1.

Gabelle A, Jaussent I, Bouallègue FB, Lehmann S, Lopez R, Barateau L, Grasselli C, Pesenti C, de Verbizier D, Béziat S, Mariano-Goulart D, Carlander B, Dauvilliers Y; Alzheimer's Disease Neuroimaging Initiative; Multi-Domain Intervention Alzheimer's Prevention Trial study groups.

Ann Neurol. 2019 Jan;85(1):74-83. doi: 10.1002/ana.25373. Epub 2018 Dec 19.

PMID:
30387527
2.

Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.

Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group.

Lancet Neurol. 2017 May;16(5):377-389. doi: 10.1016/S1474-4422(17)30040-6. Epub 2017 Mar 27.

PMID:
28359749
3.

[Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].

Gasnier M, Pelissolo A, Bondolfi G, Pelissolo S, Tomba M, Mallet L, N'diaye K.

Encephale. 2017 Dec;43(6):594-599. doi: 10.1016/j.encep.2016.10.004. Epub 2016 Nov 22. Review. French.

PMID:
27887679
4.

MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.

Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, Cuffi MN, Bordes S, Gasnier Y, Robert P, Bories L, Rouaud O, Desclaux F, Sudres K, Bonnefoy M, Pesce A, Dufouil C, Lehericy S, Chupin M, Mangin JF, Payoux P, Adel D, Legrand P, Catheline D, Kanony C, Zaim M, Molinier L, Costa N, Delrieu J, Voisin T, Faisant C, Lala F, Nourhashémi F, Rolland Y, Van Kan GA, Dupuy C, Cantet C, Cestac P, Belleville S, Willis S, Cesari M, Weiner MW, Soto ME, Ousset PJ, Andrieu S.

J Prev Alzheimers Dis. 2014 Jun;1(1):13-22.

5.

The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.

Le Duff F, Develay AE, Quetel J, Lafay P, Schück S, Pradier C, Robert P; French National Alzheimer dataBank (BNA).

J Alzheimers Dis. 2012;29(4):891-902. doi: 10.3233/JAD-2012-111943.

PMID:
22366771
6.

VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety.

Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, El Mestikawy S.

J Neurosci. 2010 Feb 10;30(6):2198-210. doi: 10.1523/JNEUROSCI.5196-09.2010.

7.

Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells.

Bigot A, Klein AF, Gasnier E, Jacquemin V, Ravassard P, Butler-Browne G, Mouly V, Furling D.

Am J Pathol. 2009 Apr;174(4):1435-42. doi: 10.2353/ajpath.2009.080560. Epub 2009 Feb 26.

8.

Molecular and cellular basis of lysosomal transmembrane protein dysfunction.

Ruivo R, Anne C, Sagné C, Gasnier B.

Biochim Biophys Acta. 2009 Apr;1793(4):636-49. doi: 10.1016/j.bbamcr.2008.12.008. Epub 2008 Dec 24. Review.

9.

Molecular pathogenesis of sialic acid storage diseases: insight gained from four missense mutations and a putative polymorphism of human sialin.

Ruivo R, Sharifi A, Boubekeur S, Morin P, Anne C, Debacker C, Graziano JC, Sagné C, Gasnier B.

Biol Cell. 2008 Sep;100(9):551-9. doi: 10.1042/BC20070166.

PMID:
18399798
10.

The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone.

Gras C, Amilhon B, Lepicard EM, Poirel O, Vinatier J, Herbin M, Dumas S, Tzavara ET, Wade MR, Nomikos GG, Hanoun N, Saurini F, Kemel ML, Gasnier B, Giros B, El Mestikawy S.

Nat Neurosci. 2008 Mar;11(3):292-300. doi: 10.1038/nn2052. Epub 2008 Feb 17.

PMID:
18278042
11.

The SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids.

Gasnier B.

Pflugers Arch. 2004 Feb;447(5):756-9. Epub 2003 May 16. Review.

PMID:
12750892
12.

Tumor necrosis factor-alpha inhibits leydig cell steroidogenesis through a decrease in steroidogenic acute regulatory protein expression.

Mauduit C, Gasnier F, Rey C, Chauvin MA, Stocco DM, Louisot P, Benahmed M.

Endocrinology. 1998 Jun;139(6):2863-8.

PMID:
9607795

Supplemental Content

Loading ...
Support Center